Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1 Phenyl 1 Diethylaminocarbonyl 2 Aminomethylcyclopropane Hcl
2. 1-phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane Hcl
3. F 2207
4. F-2207
5. F2207
6. Ixel
7. Midalcipran
8. Milnacipran
9. Milnacipran Hydrochloride
10. Savella
1. Milnacipran Hydrochloride
2. 101152-94-7
3. 105310-47-2
4. Nsc-759806
5. 1159813-27-0
6. 2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropanecarboxamide Hcl
7. Schembl1156056
8. Chembl4297064
9. Pharmakon1600-01504815
10. Act02608
11. Mfcd00901293
12. Mfcd01735755
13. Nsc759806
14. Akos025401404
15. Ac-1532
16. Ccg-213316
17. Ls-14442
18. Sy069684
19. 2-(dimethylamino)-4-pyrimidinecarboxylicacid
20. Ft-0672407
21. Ft-0672408
22. Y10009
23. A800340
24. 1-phenyl-1-diethyl-amino-carbonyl-2-aminomethylcyclopropane Hydrochloride
25. 2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropanecarboxamidehydrochloride
26. (1r,2s)-rel-2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropanecarboxamide Hydrochloride
27. 2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropane-1-carboxamide;hydrochloride
| Molecular Weight | 282.81 g/mol |
|---|---|
| Molecular Formula | C15H23ClN2O |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 5 |
| Exact Mass | 282.1498911 g/mol |
| Monoisotopic Mass | 282.1498911 g/mol |
| Topological Polar Surface Area | 46.3 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 295 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Analgesics, Non-Narcotic
A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)
Serotonin and Noradrenaline Reuptake Inhibitors
Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS. (See all compounds classified as Serotonin and Noradrenaline Reuptake Inhibitors.)
ABOUT THIS PAGE
48
PharmaCompass offers a list of Pharmakon1600-01504815 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pharmakon1600-01504815 manufacturer or Pharmakon1600-01504815 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pharmakon1600-01504815 manufacturer or Pharmakon1600-01504815 supplier.
PharmaCompass also assists you with knowing the Pharmakon1600-01504815 API Price utilized in the formulation of products. Pharmakon1600-01504815 API Price is not always fixed or binding as the Pharmakon1600-01504815 Price is obtained through a variety of data sources. The Pharmakon1600-01504815 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pharmakon1600-01504815 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pharmakon1600-01504815, including repackagers and relabelers. The FDA regulates Pharmakon1600-01504815 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pharmakon1600-01504815 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pharmakon1600-01504815 supplier is an individual or a company that provides Pharmakon1600-01504815 active pharmaceutical ingredient (API) or Pharmakon1600-01504815 finished formulations upon request. The Pharmakon1600-01504815 suppliers may include Pharmakon1600-01504815 API manufacturers, exporters, distributors and traders.
Pharmakon1600-01504815 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pharmakon1600-01504815 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pharmakon1600-01504815 GMP manufacturer or Pharmakon1600-01504815 GMP API supplier for your needs.
A Pharmakon1600-01504815 CoA (Certificate of Analysis) is a formal document that attests to Pharmakon1600-01504815's compliance with Pharmakon1600-01504815 specifications and serves as a tool for batch-level quality control.
Pharmakon1600-01504815 CoA mostly includes findings from lab analyses of a specific batch. For each Pharmakon1600-01504815 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pharmakon1600-01504815 may be tested according to a variety of international standards, such as European Pharmacopoeia (Pharmakon1600-01504815 EP), Pharmakon1600-01504815 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pharmakon1600-01504815 USP).
